Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-23

Clinical Trial Update: Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus [Phase 2]

View source ↗

Summary

Phase 2 trial of a gastrin receptor antagonist in Barrett's Esophagus completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Columbia University | Conditions: Barrett's Esophagus | Phase 2 | Status: COMPLETED | Results posted: 2021-11-23